1. Home
  2. Stock quotes
  3. Eagle Pharmaceuticals
  4. Financial Statements
  5. Balance Sheet
  6. Cash and Cash Equivalents
Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%
mail-toReport an Error

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Cash and Cash Equivalents 2011-2024 | EGRX

Annual Cash and Cash Equivalents Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
55.3 M 97.7 M 103 M 110 M 78.8 M 115 M 52.8 M 79.1 M 34.9 M 9.97 M 5.07 M -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
115 M 5.07 M 67.4 M

Quarterly Cash and Cash Equivalents Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
15.4 M 21.9 M 55.3 M 15.4 M 36.6 M 69.5 M 97.7 M 99.7 M 109 M 105 M 103 M 103 M 103 M 103 M 110 M 110 M 110 M 110 M 78.8 M 78.8 M 78.8 M 78.8 M 115 M 115 M 115 M 115 M 52.8 M 52.8 M 52.8 M 52.8 M 79.1 M 79.1 M 79.1 M 79.1 M 34.9 M 34.9 M 34.9 M 34.9 M 9.97 M 10.5 M 10.5 M 3.65 M - 5.07 M - - - 8.1 M - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
115 M 3.65 M 67.4 M